WEDNESDAY, NOV 4, 8:00 AM
Loel S. Solomon, PhD
Leader in prevention and community health programs
A Whole Person, Whole Community Approach to Obesity Prevention and Treatment
Community Health Kaiser Permanente
Loel Solomon, PhD, MPP, joined Kaiser Permanente’s Community Benefit Program in 2003 and serves as Vice President for Community Health. In this position, Dr. Solomon works with health plan and medical group leaders to establish the strategic direction for Kaiser Permanente’s multi-faceted approach to prevention and community health and develops national partnerships to advance those ends. He was a co-founder of the Convergence Partnership, a collaborative of national funders working to advance policy and environmental approaches to community health, and currently serves on the Convergence Partnership’s steering committee. Dr. Solomon also leads Kaiser Permanente’s Community Benefit Community of Practice and oversees the program’s evaluation and community health needs assessment activities. Prior to coming to Kaiser Permanente, Dr. Solomon served as Deputy Director of the California Office of Statewide Health Planning and Development (OSHPD) for Healthcare Quality and Analysis where he oversaw the state’s hospital outcomes reporting program, analyses of racial and ethnic health disparities and dissemination of healthcare data to researchers and members of the public. He served as a senior manager at the Lewin Group in Washington, DC and as a member of Senator Edward Kennedy’s health staff. Dr. Solomon received his PhD in Health Policy from Harvard University and a Master of Public Policy degree at University of California, Berkeley.
FRIDAY, NOV 6, 11:00 AM
Jan Nedergaard, PhD
Pioneer in brown adipose tissue research
Brown Fat – A burning (t)issue
Dean of Biology,
The Wenner-Gren Institute,
Jan Nedergaard, PhD, is professor of physiology at the Wenner-Gren Institute of Stockholm University. Dr. Nedergaard began his career as an instructor at the Wenner-Gren Institute and served in various positions until his appointment to professor in 1999. He has been working in the field of brown adipose tissue for 40 years, and his research focuses on how brown adipose tissue affects regulation of energy expenditure and thermogenesis. In 2007, he and collaborators were the first to formulate that there was evidence that brown adipose tissue actually exists in adult humans. He showed the same year that brown and white adipocytes were of different origin, brown being of myogenic origin. Later he has demonstrated the significance of brown adipose tissue for counteracting obesity (2009) and that the “brite”/”beige” adipocytes are molecularly different from brown adipocytes (2010) but are thermogenically competent (2013). Dr. Nedergaard has been Dean of Biology at Stockholm University and is a member of the Royal Swedish Academy of Sciences and serves as the secretary of its National Committee for Physiology. He has authored or co-authored 174 peer-reviewed publications and 120 review articles, some being basic reading for newcomers in the field. Dr. Nedergaard received his BS in chemistry and biology at the University of Gothenburg and his PhD at Stockholm University.
WEDNESDAY, NOV 4, 1:30 PM
Carel le Roux, FRCP, FRCPath, PhD
Presenting as a part of the ASMBS Integrated Health Program
Chair of Pathology and Chair of Experimental Pathology
Diabetes Complications Research Centre, University College Dublin
Carel le Roux, FRCP, FRCPath, PhD, graduated from medical school in Pretoria South Africa, completed his Senior House Officer training at St Bartholomew’s Hospital, his Specialist Registrar training in metabolic medicine at the Hammersmith Hospitals and his PhD at Imperial College London. He was appointed as Senior Lecturer and later promoted to Reader at Imperial. He started his role as Chair of Pathology at University College Dublin in 2012 where he now works within the Diabetes Complications Research Centre. He previously received a President of Ireland Young Researcher Award, Clinician Scientist Award from the National Institute Health Research in the UK, a Wellcome Trust Clinical Research Fellowship and an Anglo American Open Scholarship.